IP Library Granted Patent US 7,790,184
Granted Patent B2
US 7,790,184 · App. 11/831,273 · Granted Sep 7, 2010

Cytochrome c synthesis inhibitors

Assignee: Washington University in St. Louis
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,184
App. No.
11/831,273
Granted
Sep 7, 2010
Kind
B2
Abstract

The invention provides methods for identifying a compound that inhibits cytochrome c synthesis. This invention further provides a method for the high throughput screening of compounds that inhibit cytochrome c synthesis.

Claims (11)

1. A method for identifying a compound that inhibits cytochrome c synthesis in a bacterial cell, the method comprising: a. contacting a transfected bacterial cell with a compound, the bacterial cell being transfected with a first expression vector encoding Ccm proteins and a second expression vector encoding a cytochrome c reporter protein, wherein the bacterial cell has a chromosomal disruption in the region encoding the Ccm proteins; and b. determining the amount of cytochrome c reporter protein produced in the presence of the compound relative to the amount produced in the absence of the compound, wherein a decrease in amount is an indication that the compound inhibits the synthesis of cytochrome c.

2. The method of claim 1 , wherein the transfected bacterial is a gamma proteobacterium cell.

3. The method of claim 2 , wherein the transfected bacterial cell is an Escherichia coli cell.

4. The method of claim 1 , wherein the Ccm proteins coded by the first expression vector are from a gamma proteobacterium.

5. The method of claim 4 , wherein the Ccm protiens are the CcmA-H proteins of Escherichia coli.

6. The method of claim 1 , wherein the second expression vector encodes a cytochrome c:alkaline phosphate fusion protien or a cytochrome c:6xHis fusion protien.

7. The method of claim 6 , wherein the cytochrome c protien is cytochrome c 4 from Brodetella pertussis.

8. The method of claim 1 , wherein the coding region of the first expression vector is operably linked to a first inducible promoter and the coding region of the second expression vector is operably linked to a second inducible promoter.

9. The method of claim 8 , wherein the first promoter is induced by IPTG and the second promoter is induced by arabinose.

10. The method of claim 1 , wherein the transfected bacterial cell grows in the presence of exogenous amino levulinic acid (ALA).

11. The method of claim 1 , wherein the transfected bacterial cell further comprises a chromosomal disruption in the region encoding the HemA protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 3, 2017
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041884/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2007
From: KRANZ, ROBERT
To: WASHINGTON UNIVERSITY IN ST. LOUIS
Reel/Frame 019935/0190 →
Continuity (2)
Provisional Application 6082105300 · Aug 1, 2006
Related Publication 20080032313A1 · Feb 7, 2008